Anaphylaxis in Schools: Updated Guidance for UK & Ireland

New, comprehensive guidelines have been issued by the Resuscitation Council UK (RCUK) and the Anaphylaxis Campaign, specifically targeting the management of anaphylaxis in educational settings across the UK and Ireland. These updated recommendations underscore the vital importance of rapid recognition and immediate administration of adrenaline auto-injectors (AAIs) to save lives, building upon existing frameworks such as those from the Health and Safety Executive (HSE) and the Health and Safety Authority (HSA) in Ireland.

Anaphylaxis, a severe and potentially life-threatening allergic reaction, can progress rapidly. Incidents in schools, while relatively rare, can be particularly distressing and require a well-prepared and trained response. The new guidance aims to standardise best practice, ensuring that all staff are equipped with the knowledge and confidence to act effectively when a child experiences a severe allergic reaction.

Key Updates and Recommendations

The updated guidance, released in early 2024, places a strong emphasis on several critical areas:

  • Early Recognition: Training should focus on helping staff identify the signs and symptoms of anaphylaxis quickly. These can include skin reactions (hives, swelling), breathing difficulties (wheezing, gasping), circulatory issues (dizziness, collapse), and gastrointestinal symptoms (vomiting, abdominal pain). The guidance stresses that a combination of symptoms, or rapidly worsening single symptoms, should prompt immediate action.
  • Adrenaline Auto-Injector (AAI) Administration: The core of anaphylaxis treatment is the timely administration of an AAI (such as an EpiPen, Jext, or Emerade). The guidelines reiterate the importance of not delaying administration, even if there is uncertainty about whether it is a severe reaction. They highlight that a second dose may be required if symptoms do not improve after 5-10 minutes, or if they worsen.
  • Emergency Salbutamol Inhalers: While not a primary treatment for anaphylaxis, the guidance acknowledges that some children with asthma and allergies may be prescribed salbutamol. It clarifies that salbutamol should only be used for asthma symptoms and should not delay or replace adrenaline administration in cases of suspected anaphylaxis.
  • Emergency Care Plans: The importance of up-to-date and easily accessible individual healthcare plans (IHCPs) for every child at risk of anaphylaxis is strongly reinforced. These plans, developed in collaboration with parents/guardians and healthcare professionals, should clearly outline triggers, symptoms, and emergency procedures, including the specific AAI prescribed.
  • Staff Training: The guidance mandates that all staff who might be involved in responding to an anaphylactic emergency must receive appropriate training. This includes not only first aiders but also teachers, teaching assistants, and administrative staff. Training should be regularly refreshed, ideally annually, and include practical sessions on how to use AAIs correctly.
  • Stock AAIs: Schools in the UK have been permitted to hold 'spare' or 'emergency' adrenaline auto-injectors since 2017, under Regulation 238 of the Human Medicines Regulations 2012 (as amended). The new guidance encourages all schools to maintain an emergency supply of AAIs for use in pupils who have been prescribed one but do not have their own immediately available, or in cases where a child has an undiagnosed allergy. Similar provisions exist in Ireland under the Medicinal Products (Prescription and Control of Supply) Regulations 2003, as amended.

Regulatory Context and Impact

The HSE in the UK and the HSA in Ireland both advocate for robust first aid provision in workplaces, which includes educational institutions. While not legally binding in the same way as statutory regulations, guidance from bodies like RCUK and the Anaphylaxis Campaign is considered best practice and often forms the basis for inspection criteria and legal defence in the event of an incident. Schools failing to adhere to such guidelines could face scrutiny regarding their duty of care.

The Children and Families Act 2014 in the UK places a duty on schools to make arrangements for supporting pupils with medical conditions. In Ireland, the Department of Education and Skills provides circulars and guidance on managing medical conditions in schools, aligning with the principles of these new recommendations.

Related training: If you are looking to qualify as a trainer in this area, see moving and handling trainer qualifications or explore suicide prevention trainer courses for nationally recognised UK and Ireland qualifications.

Dr. Paul Williams, a spokesperson for RCUK, stated, "Anaphylaxis is a medical emergency. Our updated guidance aims to simplify the response for school staff, empowering them to act quickly and confidently. Every second counts, and proper training combined with readily available AAIs can be the difference between life and death."

Practical Steps for Schools

To implement the new guidelines effectively, schools should consider the following practical steps:

  1. Review Policies: Update existing first aid and medical conditions policies to reflect the new recommendations, especially regarding AAI administration and emergency response protocols.
  2. Conduct a Risk Assessment: Identify pupils at risk of anaphylaxis and ensure their Individual Healthcare Plans are current and accessible to all relevant staff.
  3. Enhance Training: Ensure all staff members, not just designated first aiders, receive annual training on anaphylaxis recognition and AAI use. This training should be practical and hands-on.
  4. Check AAI Stock: Verify that any 'stock' AAIs are in date, stored correctly, and easily accessible. Ensure staff know their location and how to access them quickly.
  5. Communication with Parents: Maintain open lines of communication with parents/guardians of children with allergies, ensuring IHCPs are up-to-date and any changes in medication or condition are promptly shared.

These guidelines represent a crucial step forward in safeguarding children with severe allergies in educational environments, providing clear, actionable advice grounded in expert consensus. Adherence to these recommendations will undoubtedly enhance the safety and wellbeing of pupils across the UK and Ireland.

For organisations seeking to update their first aid training in line with the latest guidelines, including comprehensive modules on anaphylaxis management and AAI use, Abertay Training offers a range of accredited courses. More information can be found at https://www.abertaytraining.co.uk.